Arttu Reinholm
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals.
Journal: Nature microbiology
Published: August 08, 2025
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1.
Journal: Vaccine
Published: August 05, 2025
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.
Journal: Frontiers in immunology
Published: September 10, 2024
The comprehensive SARS-CoV-2 'hijackome' knowledge base.
Journal: Cell discovery
Published: April 30, 2024
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
Journal: Frontiers in immunology
Published: November 15, 2022
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
Journal: Microbiology spectrum
Published: March 09, 2022
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants.
Journal: Nature communications
Published: December 23, 2021
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
Journal: Nature communications
Published: March 18, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026